The DOI matches its Crossref record; 130 of the 130 references it cites were found in a registry or an index.
Heart Failure: Diagnosis, Management and Utilization
Open accessAbstract
Despite the advancement in medicine, management of heart failure (HF), which usually presents as a disease syndrome, has been a challenge to healthcare providers. This is reflected by the relatively higher rate of readmissions along with increased mortality and morbidity associated with HF. In this review article, we first provide a general overview of types of HF pathogenesis and diagnostic features of HF including the crucial role of exercise in determining the severity of heart failure, the efficacy of therapeutic strategies and the morbidity/mortality of HF. We then discuss the quality control measures to prevent the growing readmission rates for HF. We also attempt to elucidate published and ongoing clinical trials for HF in an effort to evaluate the standard and novel therapeutic approaches, including stem cell and gene therapies, to reduce the morbidity and mortality. Finally, we discuss the appropriate utilization/documentation and medical coding based on the severity of the HF alone and with minor and major co-morbidities. We consider that this review provides an extensive overview of the HF in terms of disease pathophysiology, management and documentation for the general readers, as well as for the clinicians/physicians/hospitalists.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Bolli, R., Chugh, A. R., D'Amario, D., Loughran, J. H., Stoddard, M. F., Ikram, S., Beache, G. M., Wagner, S. G., Leri, A., Hosoda, T., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61590-0 · Cited by 1,288
RetractedMcDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab670 · Cited by 19,442
2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536
Ahmed, A., Jorna, T., & Bhandari, S. (2016) · Nephron · doi:10.1159/000447068 · Cited by 11,717
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214
The SOLVD Investigators* (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250501 · Cited by 8,029
Angiotensin-neprilysin inhibition versus enalapril in heart failure
McMurray, J. J. V., Packer, M., Desai, A. S., Gong, J., Lefkowitz, M. P., Rizkala, A. R., Rouleau, J. L., Shi, V. C., Solomon, S. D., Swedberg, K., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1409077 · Cited by 6,957
Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure
Bardy, G. H., Lee, K. L., Mark, D. B., Poole, J. E., Packer, D. L., Boineau, R., Domanski, M., Troutman, C., Anderson, J., Johnson, G., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043399 · Cited by 6,552
Effects of Enalapril on Mortality in Severe Congestive Heart Failure
The Consensus Trial Study Group* (1987) · New England Journal of Medicine · doi:10.1056/nejm198706043162301 · Cited by 5,121
The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial
(1999) · The Lancet · doi:10.1016/s0140-6736(98)11181-9 · Cited by 4,929
Swedberg, K., & Kjekshus, J. (1988) · The American Journal of Cardiology · doi:10.1016/s0002-9149(88)80087-0 · Cited by 3,762
(1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271003 · Cited by 3,725
A Novel Paradigm for Heart Failure With Preserved Ejection Fraction
Paulus, W. J., & Tschöpe, C. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.02.092 · Cited by 3,564
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008
Dickstein, K., Authors/Task Force Members, Cohen-Solal, A., Filippatos, G., McMurray, J. J. V., Ponikowski, P., Poole-Wilson, P. A., Strömberg, A., van Veldhuisen, D. J., Atar, D., et al. (2008) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2008.08.005 · Cited by 3,512
Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events
Moss, A. J., Hall, W. J., Cannom, D. S., Klein, H., Brown, M. W., Daubert, J. P., Estes, N. A. M., Foster, E., Greenberg, H., Higgins, S. L., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0906431 · Cited by 3,157
Eplerenone in patients with systolic heart failure and mild symptoms
Zannad, F., McMurray, J. J. V., Krum, H., van Veldhuisen, D. J., Swedberg, K., Shi, H., Vincent, J., Pocock, S. J., & Pitt, B. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009492 · Cited by 3,111
A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart Failure
Cohn, J. N., & Tognoni, G. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010713 · Cited by 3,108
Yusuf, S., Pfeffer, M. A., Swedberg, K., Granger, C. B., Held, P., McMurray, J. J., Michelson, E. L., Olofsson, B., & Östergren, J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14285-7 · Cited by 2,994
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
PITT, B., ZANNAD, F., REMME, W. J., CODY, R., CASTAIGNE, A., PEREZ, A., PALENSKY, J., & WITTES, J. (2000) · Survey of Anesthesiology · doi:10.1097/00132586-200006000-00059 · Cited by 2,927
Heidenreich, P. A., Albert, N. M., Allen, L. A., Bluemke, D. A., Butler, J., Fonarow, G. C., Ikonomidis, J. S., Khavjou, O., Konstam, M. A., Maddox, T. M., et al. (2013) · Circulation: Heart Failure · doi:10.1161/hhf.0b013e318291329a · Cited by 2,804
McMurray, J. J., Östergren, J., Swedberg, K., Granger, C. B., Held, P., Michelson, E. L., Olofsson, B., Yusuf, S., & Pfeffer, M. A. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14283-3 · Cited by 2,604
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study
Swedberg, K., Komajda, M., Böhm, M., Borer, J. S., Ford, I., Dubost-Brama, A., Lerebours, G., & Tavazzi, L. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61198-1 · Cited by 2,563
Heart Rate, Life Expectancy and the Cardiovascular System: Therapeutic Considerations
Boudoulas, K. D., Borer, J. S., & Boudoulas, H. (2015) · Cardiology · doi:10.1159/000435947 · Cited by 1,938
Poole-Wilson, P. A., Swedberg, K., Cleland, J. G., Di Lenarda, A., Hanrath, P., Komajda, M., Lubsen, J., Lutiger, B., Metra, M., Remme, W. J., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13800-7 · Cited by 1,872
Abraham, W. T., Adamson, P. B., Bourge, R. C., Aaron, M. F., Costanzo, M. R., Stevenson, L. W., Strickland, W., Neelagaru, S., Raval, N., Krueger, S., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60101-3 · Cited by 1,744
Roger, V. L. (2013) · Circulation Research · doi:10.1161/circresaha.113.300268 · Cited by 1,728 · cited 4×
“An increase in the prevalence of co-morbid conditions and risk factors, such as increased body mass index (BMI), metabolic syndrome, elevated apolipoprotein B/apolipoprotein A ratio and cigarette smoking, in these populations with relatively increased life expectancy may be some of the reasons behind the increased pre…”
BackgroundResultInfluentialGranger, C. B., McMurray, J. J., Yusuf, S., Held, P., Michelson, E. L., Olofsson, B., Östergren, J., Pfeffer, M. A., & Swedberg, K. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14284-5 · Cited by 1,686
Konstam, M. A. (2007) · JAMA · doi:10.1001/jama.297.12.1319 · Cited by 1,628
Rosuvastatin in older patients with systolic heart failure
Kjekshus, J., Apetrei, E., Barrios, V., Böhm, M., Cleland, J. G. F., Cornel, J. H., Dunselman, P., Fonseca, C., Goudev, A., Grande, P., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa0706201 · Cited by 1,487
Makkar, R. R., Smith, R. R., Cheng, K., Malliaras, K., Thomson, L. E., Berman, D., Czer, L. S., Marbán, L., Mendizabal, A., Johnston, P. V., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60195-0 · Cited by 1,422
HFSA 2010 Comprehensive Heart Failure Practice Guideline
Heart Failure Society of America (2010) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2010.04.004 · Cited by 1,290
Effect of Nesiritide in Patients with Acute Decompensated Heart Failure
O'Connor, C. M., Starling, R. C., Hernandez, A. F., Armstrong, P. W., Dickstein, K., Hasselblad, V., Heizer, G. M., Komajda, M., Massie, B. M., McMurray, J. J. V., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1100171 · Cited by 1,252
Hare, J. M., Fishman, J. E., Gerstenblith, G., DiFede Velazquez, D. L., Zambrano, J. P., Suncion, V. Y., Tracy, M., Ghersin, E., Johnston, P. V., Brinker, J. A., et al. (2012) · JAMA · doi:10.1001/jama.2012.25321 · Cited by 1,192
Böhm, M., Swedberg, K., Komajda, M., Borer, J. S., Ford, I., Dubost-Brama, A., Lerebours, G., & Tavazzi, L. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61259-7 · Cited by 1,099
Dharmarajan, K., Hsieh, A. F., Lin, Z., Bueno, H., Ross, J. S., Horwitz, L. I., Barreto-Filho, J. A., Kim, N., Bernheim, S. M., Suter, L. G., et al. (2013) · JAMA · doi:10.1001/jama.2012.216476 · Cited by 1,060
The Evolving Concept of a Stem Cell
Blau, H. M., Brazelton, T. R., & Weimann, J. M. (2001) · Cell · doi:10.1016/s0092-8674(01)00409-3 · Cited by 1,046
(2002) · ACC Current Journal Review · doi:10.1016/s1062-1458(02)00795-x · Cited by 980
Predictors of mortality and morbidity in patients with chronic heart failure
Pocock, S. J., Wang, D., Pfeffer, M. A., Yusuf, S., McMurray, J. J. V., Swedberg, K. B., Östergren, J., Michelson, E. L., Pieper, K. S., & Granger, C. B. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi555 · Cited by 973
Digoxin in Heart Failure with a Reduced Ejection Fraction: A Risk Factor or a Risk Marker?
Konstantinou, D. M., Karvounis, H., & Giannakoulas, G. (2016) · Cardiology · doi:10.1159/000444078 · Cited by 870
Jessup, M., Greenberg, B., Mancini, D., Cappola, T., Pauly, D. F., Jaski, B., Yaroshinsky, A., Zsebo, K. M., Dittrich, H., & Hajjar, R. J. (2011) · Circulation · doi:10.1161/circulationaha.111.022889 · Cited by 760
Feltner, C., Jones, C. D., Cené, C. W., Zheng, Z.-J., Sueta, C. A., Coker-Schwimmer, E. J. L., Arvanitis, M., Lohr, K. N., Middleton, J. C., & Jonas, D. E. (2014) · Annals of Internal Medicine · doi:10.7326/m14-0083 · Cited by 681
Tang, W. H. W., Wang, Z., Fan, Y., Levison, B., Hazen, J. E., Donahue, L. M., Wu, Y., & Hazen, S. L. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.02.617 · Cited by 681
Inflammatory mediators in chronic heart failure: an overview
Anker, S. D., & von Haehling, S. (2004) · Heart · doi:10.1136/hrt.2002.007005 · Cited by 627
Structured telephone support or telemonitoring programmes for patients with chronic heart failure
Inglis, S. C., Clark, R. A., McAlister, F. A., Ball, J., Lewinter, C., Cullington, D., Stewart, S., & Cleland, J. G. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007228.pub2 · Cited by 614
Rehospitalization for Heart Failure: Predict or Prevent?
Desai, A. S., & Stevenson, L. W. (2012) · Circulation · doi:10.1161/circulationaha.112.125435 · Cited by 613
Freyman, T., Polin, G., Osman, H., Crary, J., Lu, M., Cheng, L., Palasis, M., & Wilensky, R. L. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi818 · Cited by 613
Heldman, A. W., DiFede, D. L., Fishman, J. E., Zambrano, J. P., Trachtenberg, B. H., Karantalis, V., Mushtaq, M., Williams, A. R., Suncion, V. Y., McNiece, I. K., et al. (2014) · JAMA · doi:10.1001/jama.2013.282909 · Cited by 570
Perin, E. C., Willerson, J. T., Pepine, C. J., Henry, T. D., Ellis, S. G., Zhao, D. X. M., Silva, G. V., Lai, D., Thomas, J. D., Kronenberg, M. W., et al. (2012) · JAMA · doi:10.1001/jama.2012.418 · Cited by 460
Jaski, B. E., Jessup, M. L., Mancini, D. M., Cappola, T. P., Pauly, D. F., Greenberg, B., Borow, K., Dittrich, H., Zsebo, K. M., & Hajjar, R. J. (2009) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2009.01.013 · Cited by 457
Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT)
Maisel, A., Hollander, J. E., Guss, D., McCullough, P., Nowak, R., Green, G., Saltzberg, M., Ellison, S. R., Bhalla, M. A., Bhalla, V., et al. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.06.015 · Cited by 431
Yusuf, S., Pfeffer, Swedberg, K. B., Granger, C. B., Held, P. H., McMurray, J. J. V., Michelson, E. L., Olofsson, B., & Östergren, J. (2003) · Cited by 431
Biomarkers and diagnostics in heart failure
Gaggin, H. K., & Januzzi, J. L. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.12.014 · Cited by 423
Whellan, D. J., Ousdigian, K. T., Al-Khatib, S. M., Pu, W., Sarkar, S., Porter, C. B., Pavri, B. B., & O'Connor, C. M. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.11.089 · Cited by 374
McMurray, J. J. V., Teerlink, J. R., Cotter, G., Bourge, R. C., Cleland, J. G. F., Jondeau, G., Krum, H., Metra, M., O’Connor, C. M., Parker, J. D., et al. (2007) · JAMA · doi:10.1001/jama.298.17.2009 · Cited by 360
Krumholz, H. M., Lin, Z., Keenan, P. S., Chen, J., Ross, J. S., Drye, E. E., Bernheim, S. M., Wang, Y., Bradley, E. H., Han, L. F., et al. (2013) · JAMA · doi:10.1001/jama.2013.333 · Cited by 354
Karantalis, V., DiFede, D. L., Gerstenblith, G., Pham, S., Symes, J., Zambrano, J. P., Fishman, J., Pattany, P., McNiece, I., Conte, J., et al. (2014) · Circulation Research · doi:10.1161/circresaha.114.303180 · Cited by 348
Hemodynamic Basis of Exercise Limitation in Patients With Heart Failure and Normal Ejection Fraction
Maeder, M. T., Thompson, B. R., Brunner-La Rocca, H.-P., & Kaye, D. M. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.04.040 · Cited by 330
Ouwerkerk, W., Voors, A. A., & Zwinderman, A. H. (2014) · JACC: Heart Failure · doi:10.1016/j.jchf.2014.04.006 · Cited by 328
Gheorghiade, M., Böhm, M., Greene, S. J., Fonarow, G. C., Lewis, E. F., Zannad, F., Solomon, S. D., Baschiera, F., Botha, J., Hua, T. A., et al. (2013) · JAMA · doi:10.1001/jama.2013.1954 · Cited by 328
Effect of Inorganic Nitrate on Exercise Capacity in Heart Failure With Preserved Ejection Fraction
Zamani, P., Rawat, D., Shiva-Kumar, P., Geraci, S., Bhuva, R., Konda, P., Doulias, P.-T., Ischiropoulos, H., Townsend, R. R., Margulies, K. B., et al. (2015) · Circulation · doi:10.1161/circulationaha.114.012957 · Cited by 307
Muscle oxygen transport and utilization in heart failure: implications for exercise (in)tolerance
Poole, D. C., Hirai, D. M., Copp, S. W., & Musch, T. I. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00943.2011 · Cited by 285
Giamouzis, G., Kalogeropoulos, A., Georgiopoulou, V., Laskar, S., Smith, A. L., Dunbar, S., Triposkiadis, F., & Butler, J. (2011) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2010.08.010 · Cited by 282
Patel, A. N., Geffner, L., Viña, R. F., Saslavsky, J., Urschel, H. C., Kormos, R. L., & Benetti, F. (2005) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2005.07.056 · Cited by 272
Fonarow, G. C. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.13.1469 · Cited by 271
Lifetime Costs of Medical Care After Heart Failure Diagnosis
Dunlay, S. M., Shah, N. D., Shi, Q., Morlan, B., VanHouten, H., Hall Long, K., & Roger, V. L. (2011) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.110.957225 · Cited by 263
Januzzi, J. L., Sakhuja, R., O’Donoghue, M., Baggish, A. L., Anwaruddin, S., Chae, C. U., Cameron, R., Krauser, D. G., Tung, R., Camargo, C. A., et al. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.3.315 · Cited by 261
Angadi, S. S., Mookadam, F., Lee, C. D., Tucker, W. J., Haykowsky, M. J., & Gaesser, G. A. (2015) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00518.2014 · Cited by 260
Intersections Between Microbiome and Heart Failure: Revisiting the Gut Hypothesis
Nagatomo, Y., & Tang, W. H. W. (2015) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2015.09.017 · Cited by 259
Emerging Biomarkers in Heart Failure
van Kimmenade, R. R. J., & Januzzi, J. L. (2012) · Clinical Chemistry · doi:10.1373/clinchem.2011.165720 · Cited by 257
VEGF gene therapy: therapeutic angiogenesis in the clinic and beyond
Giacca, M., & Zacchigna, S. (2012) · Gene Therapy · doi:10.1038/gt.2012.17 · Cited by 252
Abnormal Haemodynamic Response to Exercise in Heart Failure with Preserved Ejection Fraction
Bhella, P. S., Prasad, A., Heinicke, K., Hastings, J. L., Arbab-Zadeh, A., Adams-Huet, B., Pacini, E. L., Shibata, S., Palmer, M. D., Newcomer, B. R., et al. (2011) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfr133 · Cited by 238
Progresses towards safe and efficient gene therapy vectors
Chira, S., Jackson, C. S., Oprea, I., Ozturk, F., Pepper, M. S., Diaconu, I., Braicu, C., Raduly, L.-Z., Calin, G. A., & Berindan-Neagoe, I. (2015) · Oncotarget · doi:10.18632/oncotarget.5169 · Cited by 219
Assmus, B., Fischer-Rasokat, U., Honold, J., Seeger, F. H., Fichtlscherer, S., Tonn, T., Seifried, E., Schächinger, V., Dimmeler, S., & Zeiher, A. M. (2007) · Circulation Research · doi:10.1161/01.res.0000264508.47717.6b · Cited by 217
Long-term survival of cancer patients compared to heart failure and stroke: A systematic review
Askoxylakis, V., Thieke, C., Pleger, S. T., Most, P., Tanner, J., Lindel, K., Katus, H. A., Debus, J., & Bischof, M. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-105 · Cited by 217
Donze, J., Lipsitz, S., Bates, D. W., & Schnipper, J. L. (2013) · BMJ · doi:10.1136/bmj.f7171 · Cited by 209
Svensson, E. C., Marshall, D. J., Woodard, K., Lin, H., Jiang, F., Chu, L., & Leiden, J. M. (1999) · Circulation · doi:10.1161/01.cir.99.2.201 · Cited by 207
Home Monitoring for Heart Failure Management
Bui, A. L., & Fonarow, G. C. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.09.044 · Cited by 203
Rajaram, R., Chung, J. W., Kinnier, C. V., Barnard, C., Mohanty, S., Pavey, E. S., McHugh, M. C., & Bilimoria, K. Y. (2015) · JAMA · doi:10.1001/jama.2015.8609 · Cited by 201
ABC of heart failure: Clinical features and complications
Watson, R. D. S. (2000) · BMJ · doi:10.1136/bmj.320.7229.236 · Cited by 192
Torre-Amione, G., Anker, S. D., Bourge, R. C., Colucci, W. S., Greenberg, B. H., Hildebrandt, P., Keren, A., Motro, M., Moyé, L. A., Otterstad, J. E., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60134-8 · Cited by 178
Vrtovec, B., Poglajen, G., Lezaic, L., Sever, M., Socan, A., Domanovic, D., Cernelc, P., Torre-Amione, G., Haddad, F., & Wu, J. C. (2013) · Circulation · doi:10.1161/circulationaha.112.000230 · Cited by 177
McMurray, J. J. V., Packer, M., Desai, A. S., Gong, J., Lefkowitz, M., Rizkala, A. R., Rouleau, J. L., Shi, V. C., Solomon, S. D., Swedberg, K., et al. (2014) · European Journal of Heart Failure · doi:10.1002/ejhf.115 · Cited by 175
Exercise Training as Therapy for Heart Failure: Current Status and Future Directions
Fleg, J. L., Cooper, L. S., Borlaug, B. A., Haykowsky, M. J., Kraus, W. E., Levine, B. D., Pfeffer, M. A., Piña, I. L., Poole, D. C., Reeves, G. R., et al. (2015) · Circulation: Heart Failure · doi:10.1161/circheartfailure.113.001420 · Cited by 172
Use of NT-proBNP in Routine Testing and Comparison to BNP
Pfister, R., Scholz, M., Wielckens, K., Erdmann, E., & Schneider, C. A. (2004) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2003.12.012 · Cited by 165
Bekelman, D. B., Plomondon, M. E., Carey, E. P., Sullivan, M. D., Nelson, K. M., Hattler, B., McBryde, C. F., Lehmann, K. G., Gianola, K., Heidenreich, P. A., et al. (2015) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.0315 · Cited by 159
Exercise training in chronic heart failure: improving skeletal muscle O2transport and utilization
Hirai, D. M., Musch, T. I., & Poole, D. C. (2015) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00469.2015 · Cited by 158
Rationale and Design of The SOluble guanylate Cyclase StimulatoR in HeArT FailurE Studies (SOCRATES)
Pieske, B. M., Butler, J., Filippatos, G. S., Lam, C. S. P., Maggioni, A. P., Ponikowski, P. P., Shah, S. J., Solomon, S. D., Kraigher‐Krainer, E., Samano, E. S. T., et al. (2014) · European Journal of Heart Failure · doi:10.1002/ejhf.135 · Cited by 144
Novel therapeutic targets for the treatment of heart failure
Tamargo, J. L., & Lopez-Sendon, J. L. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3431 · Cited by 142
Ohtani, T., Mohammed, S. F., Yamamoto, K., Dunlay, S. M., Weston, S. A., Sakata, Y., Rodeheffer, R. J., Roger, V. L., & Redfield, M. M. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs135 · Cited by 141
Trachtenberg, B. H., Velazquez, D. L., Williams, A. R., McNiece, I., Fishman, J. E., Nguyen, K., Rouy, D., Altman, P. A., Schwarz, R., Mendizabal, A. M., et al. (2011) · American Heart Journal · doi:10.1016/j.ahj.2010.11.024 · Cited by 135
Novel biomarkers in chronic heart failure
Ahmad, T., Fiuzat, M., Felker, G. M., & O’Connor, C. M. (2012) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2012.37 · Cited by 134
How can we cure a heart “in flame”? A translational view on inflammation in heart failure
Hofmann, U., & Frantz, S. (2013) · Basic Research in Cardiology · doi:10.1007/s00395-013-0356-y · Cited by 118
VanSuch, M., Naessens, J. M., Stroebel, R. J., Huddleston, J. M., & Williams, A. R. (2006) · BMJ Quality & Safety · doi:10.1136/qshc.2005.017640 · Cited by 117
Recent Developments in Heart Failure
Dassanayaka, S., & Jones, S. P. (2015) · Circulation Research · doi:10.1161/circresaha.115.305765 · Cited by 116
Targeting cardiac β-adrenergic signaling via GRK2 inhibition for heart failure therapy
Cannavò, A., Liccardo, D., & Koch, W. J. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00264 · Cited by 115
Jolly, K. B., Taylor, R. S., Lip, G. Y. H., Davies, M., Davis, R., Mant, J., Singh, S., Greenfield, S., Ingram, J. T., Stubley, J., et al. (2009) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfn029 · Cited by 113
Exercise intolerance in heart failure with preserved ejection fraction: more than a heart problem.
Upadhya, B., Haykowsky, M. J., Eggebeen, J., & Kitzman, D. W. (2015) · 老年心脏病学杂志:英文版 · doi:10.11909/j.issn.1671-5411.2015.03.013 · Cited by 112
Redfield, M. M., Borlaug, B. A., Lewis, G. D., Mohammed, S. F., Semigran, M. J., LeWinter, M. M., Deswal, A. M., Hernandez, A. F., Lee, K. L., & Braunwald, E. (2012) · Circulation Heart Failure · doi:10.1161/circheartfailure.112.969071 · Cited by 110
Maries, L., & Maniţiu, I. (2013) · Cardiovascular journal of South Africa/Cardiovascular journal of Southern Africa · doi:10.5830/cvja-2013-055 · Cited by 107
Structured telephone support or telemonitoring programmes for patients with chronic heart failure
Inglis, S. C. (2010) · Journal of Evidence-Based Medicine · doi:10.1111/j.1756-5391.2010.01104.x · Cited by 97
The role of inflammation in heart failure: new therapeutic approaches.
Oikonomou, E. K., Tousoulis, D., Siasos, G., Zaromitidou, M., Papavassiliou, A. G., & Stefanadis, C. (2011) · PubMed · Cited by 91
Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-1) Trial Design
Bartúnek, J., Davison, B. A., Sherman, W., Povsic, T. J., Henry, T. D., Gersh, B. J., Metra, M., Filippatos, G. S., Hajjar, R. J., Behfar, A., et al. (2015) · European Journal of Heart Failure · doi:10.1002/ejhf.434 · Cited by 88
Recent Trends in Heart Failure-related Mortality: United States, 2000-2014.
Ni, H., & Xu, J. (2015) · PubMed · Cited by 81
Cardiac tissue engineering and regeneration using cell-based therapy
Alrefai, M., Murali, D., Paul, A., Ridwan, K., Connell, J., & Shum‐Tim, D. (2015) · Stem Cells and Cloning Advances and Applications · doi:10.2147/sccaa.s54204 · Cited by 80
Exercise intolerance in heart failure with preserved ejection fraction: more than a heart problem
..., B., Upadhya, ', M., Haykowsky, M. J., Joel, J., Eggebeen, Dalane, & Kitzman (2015) · 老年心脏病学杂志:英文版 · Cited by 76
West, R. L., Liang, L., Fonarow, G. C., Kociol, R. D., Mills, R. M., O’Connor, C. M., & Hernandez, A. F. (2011) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfr064 · Cited by 75
Beeri, R., Chaput, M., Guerrero, J. L., Kawase, Y., Yosefy, C., Abedat, S., Karakikes, I., Morel, C., Tisosky, A., Sullivan, S., et al. (2010) · Circulation: Heart Failure · doi:10.1161/circheartfailure.109.891184 · Cited by 69
Effect of Serelaxin on Mode of Death in Acute Heart Failure
Felker, G. M., Teerlink, J. R., Butler, J., Hernandez, A. F., Miller, A. B., Cotter, G., Davison, B. A., Filippatos, G. S., Greenberg, B., Ponikowski, P. P., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.05.071 · Cited by 69
Hospital Strategies to Reduce Heart Failure Readmissions
Butler, J., & Kalogeropoulos, A. P. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.03.066 · Cited by 65
Thomas, R., Huntley, A. L., Mann, M. K., Huws, D., Paranjothy, S., Elwyn, G. J., & Purdy, S. (2013) · Heart · doi:10.1136/heartjnl-2012-302313 · Cited by 65
Role of Inotropic Agents in the Treatment of Heart Failure
Goldhaber, J. I., & Hamilton, M. A. (2010) · Circulation · doi:10.1161/circulationaha.109.899294 · Cited by 57
The Three-Phase Terrain of Heart Failure Readmissions
Desai, A. S. (2012) · Circulation Heart Failure · doi:10.1161/circheartfailure.112.968735 · Cited by 48
Taylor, R. S., Hayward, C. J., Eyre, V., Austin, J., Davies, R., Doherty, P., Jolly, K. B., Wingham, J., van Lingen, R., Abraham, C., et al. (2015) · BMJ Open · doi:10.1136/bmjopen-2015-009994 · Cited by 44
A multi-layer monitoring system for clinical management of Congestive Heart Failure
Guidi, G., Pollonini, L., Dacso, C. C., & Iadanza, E. (2015) · BMC Medical Informatics and Decision Making · doi:10.1186/1472-6947-15-s3-s5 · Cited by 41
Acute Heart Failure: Patient Characteristics and Pathophysiology
Marti, C. N., Georgiopoulou, V. V., & Kalogeropoulos, A. P. (2013) · Current Heart Failure Reports · doi:10.1007/s11897-013-0151-y · Cited by 41
Imaging Heart Failure: Current and Future Applications
Paterson, D. I., Mielniczuk, L. M., O’Meara, E., So, A., & White, J. A. (2013) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2013.01.006 · Cited by 36
Gene Therapy Targets in Heart Failure: The Path to Translation
Raake, P. W. J., Tscheschner, H., Reinkober, J., Ritterhoff, J., Katus, H. A., Koch, W. J., & Most, P. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.148 · Cited by 31
Viral-Based Myocardial Gene Therapy Approaches to Alter Cardiac Function
Williams, M. L., & Koch, W. J. (2004) · Annual Review of Physiology · doi:10.1146/annurev.physiol.66.032102.141555 · Cited by 31
Glean, A. A., Ferguson, S. K., Holdsworth, C. T., Colburn, T. D., Wright, J. L., Fees, A. J., Hageman, K. S., Poole, D. C., & Musch, T. I. (2015) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00421.2015 · Cited by 31
The Emerging Role of Multi-Detector Computed Tomography in Heart Failure
Butler, J. (2007) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2006.11.014 · Cited by 26
Moss, J. A. (2014) · PubMed · Cited by 24
Clinical Application of Three-Dimensional Echocardiography
Morbach, C., Lin, B. A., & Sugeng, L. (2014) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2014.05.005 · Cited by 20
Predicting readmission of heart failure patients using automated follow-up calls
Inouye, S., Bouras, V., Shouldis, E., Johnstone, A., Silverzweig, Z., & Kosuri, P. (2015) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-015-0144-8 · Cited by 13
Physician-Directed Heart Failure Transitional Care Program: A Retrospective Case Review
Ota (2013) · Journal of Clinical Medicine Research · doi:10.4021/jocmr1492w · Cited by 13
Introduction of an NT-proBNP assay to an acute admission unit — A 2-year audit
Murtagh, G., Canniffe, C., Mahgoub, M., Blake, L., McCarroll, N. A., Crowley, V., Bennett, K., & Silke, B. (2008) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2008.04.021 · Cited by 12
Optimal postdischarge management of chronic HF
Scalvini, S., & Giordano, A. (2012) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2012.161 · Cited by 12
Evaluation of natriuretic peptide recommendations in heart failure clinical practice guidelines
Simons, J. E., & Don-Wauchope, A. (2015) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2015.08.022 · Cited by 7
CRT for Heart Failure and ESRD
Cleland, J. G. F., & Mareev, Y. V. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.10.022 · Cited by 2
Cited by
Martin, A. S., Abraham, D. M., Hershberger, K. A., Bhatt, D. P., Mao, L., Cui, H., Liu, J., Liu, X., Muehlbauer, M. J., Grimsrud, P. A., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.93885 · Cited by 128
Expert systems: Definitions, advantages and issues in medical field applications
Saibene, A., Assale, M., & Giltri, M. (2021) · Expert Systems with Applications · doi:10.1016/j.eswa.2021.114900 · Cited by 133
Pavlovic, N. V., GILOTRA, N. A., LEE, C. S., NDUMELE, C., MAMMOS, D., DENNISONHIMMELFARB, C., & AbshireSaylor, M. (2022) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2021.07.005 · Cited by 58
Metadata
- Authors
- Inamdar, A., & Inamdar, A.
- Venue
- Journal of Clinical Medicine
- Publisher
- MDPI AG
- Published
- 2016-06-29
- Volume
- 5
- Issue
- 7
- Pages
- 62
- ISSN
- 2077-0383 (ISSN-L)
- OpenAlex
- W2465016211
- Cited by
- 412
- References
- 130
- FWCI
- 18.92
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.